5-Aminoisoquinolinone reduces renal injury and dysfunction caused by experimental ischemia/reperfusion

Kidney International

Volumn 65, Issue 2, 2004, Pages 499-509

  Chatterjee, Prabal K ^a   Chatterjee, Bristi E ^c   Pedersen, Helene ^c   Sivarajah, Ahila ^c   McDonald, Michelle C ^c   Mota Filipe, Helder ^c   Brown, Paul A J ^c   Stewart, Keith N ^c   Cuzzocrea, Salvatore ^c   Threadgill, Michael D ^c   Thiemermann, Christoph ^b  

^a UNIVERSITY OF BRIGHTON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c NONE

Author keywords

5 aminoisoquinolinone; Ischemia; Oxidative stress; Poly (ADP ribose) polymerase; Rat; Reperfusion injury

Indexed keywords

5 AMINOISOQUINOLINE; HYDROGEN PEROXIDE; ISOQUINOLINE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CELL DAMAGE; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; INCUBATION TIME; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE CELL; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; REPERFUSION INJURY;

EID: 1642561701     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.00415.x     Document Type: Article

References (50)

1. IKAI K, UEDA K: Immunohistochemical demonstration of poly (adenosine diphosphate-ribose) synthetase in bovine tissues. J Histochem Cytochem 31:261-264, 1983
2. UEDA K, HAYAISHI O: ADP-ribosylation. Ann Rev Biochem 54:73-100, 1985
3. BERGER NA: Poly(ADP-ribose) in the cellular response to DNA damage. Rad Res 101:4-15, 1985
4. CHIARUGI A: Poly(ADP-ribose) polymerase: Killer or conspirator? The 'suicide hypothesis' revisited. Trends Pharmacol Sci 23:22-129, 2002
5. SZABÓ C, DAWSON DL: Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19:287-298, 1998
6. BÜRKLE A: Physiology and pathophysiology of poly(ADP-ribosyl)ation. BioEssays 23:795-806, 2001
7. THIEMERMANN C, BOWES J, MYINT F, VANE JR: Inhibition of the activity of poly (ADP-ribose) synthetase reduces ischemia-reperfusion injury in the heart and skeletal muscle. Proc Natl Acad Sci USA 94:679-683, 1997
8. ZINGARELLI B, CUZZOCREA S, ZSENGELLER Z, et al: Protection against myocardial ischemia and reperfusion injury by 3 aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase. Cardiovasc Res 36:205-215, 1997
9. TAKAHASHI K, GREENBERG JH, JACKSON P, et al: Neuroprotective effects of inhibiting poly(ADP-ribose) synthetase on focal cerebral ischemia in rats. J Cereb Blood Flow Metab 17:1137-1142, 1997
10. DUCROCQ S, BENJELLOUN N, PLOTKINE M, et al. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal brain. J Neurochem 74:2504-2511, 2000
11. PLASCHKE K, KOPITZ J, WEIGAND MA, et al: The neuroprotective effect of cerebral poly(ADP-ribose) polymerase inhibition in a rat model of global ischemia. Neurosci Lett 284:109-112, 2000
12. CUZZOCREA S, ZINGARELLI B, COSTANTINO G, et al: Beneficial effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) synthetase in a rat model of splanchnic artery occlusion and reperfusion. Br J Pharmacol 121:1065-1074, 1997
13. LIAUDET L, SZABÓ A, SORIANO FG, et al: Poly (ADP-ribose) synthetase mediates intestinal mucosal barrier dysfunction after mesenteric ischemia. Shock 14:134-141, 2000
14. TENTORI L, PORTARENA I, GRAZIANI G: Potential clinical applications of poly (ADP-ribose) polymerase (PARP) inhibitors. Pharmacol Res 45:73-85, 2002
15. ELIASSON MJL, SAMPEI K, MANDIR AS, et al: Poly (ADP-ribose) polymerase gene disruption renders mice resistant to cerebral ischaemia. Nat Med 3:1089-1095, 1997
16. ZINGARELLI B, SALZMAN AL, SZABÓ C: Genetic disruption of poly (ADP-ribose) synthetase inhibits the expression of P-selectin and intercellular adhesion molecule-1 in myocardial ischemia/reperfusion injury. Circ Res 83:85-94, 1998
17. SHALL S, DE MURCIA G, Poly (ADP-ribose) polymerase-1: What have we learned from the deficient mouse model? Mut Res 460:1-15, 2000
18. GRUPP IL, JACKSON TM, HAKE P, et al: Protection against hypoxiareoxygenation in the absence of poly (ADP-ribose) synthetase in isolated working hearts. J Moll Cell Cardiol 31:297-303, 1999
19. KRIBBEN A, EDELSTEIN CL, SCHRIER RW: Pathophysiology of acute renal failure. J Nephrol 12:S142-S151, 1999
20. AGRAWAL M, SWARTZ R: Acute renal failure. Am Fam Phys 61:2077-2088, 2000
21. PALLER MS: The cell biology of reperfusion injury in the kidney. J Invest Med 42:632-639, 1994
22. LIEBERTHAL W, LEVINE JS: Mechanisms of apoptosis and its potential role in renal tubular epithelial cell injury. Am J Physiol 271:F477-F488, 1996
23. STAR RA: Treatment of acute renal failure. Kidney Int 54:1817-1831, 1998
24. LAMEIRE N, VANHOLDER R: Pathophysiologic features and prevention of human and experimental acute tubular necrosis. J Am Soc Nephrol 12:S20-S32, 2001
25. CHATTERJEE PK, THIEMERMANN C: Poly (ADP-ribose) polymerase inhibitors and acute renal failure, in Therapeutic Utilities of PARP Inhibitors, edited by Zhang J, Boca Raton, CRC Press, 2002, pp 149-168
26. CHATTERJEE PK, CUZZOCREA S, THIEMERMANN C: Inhibitors of poly (ADP-ribose) synthetase protect rat proximal tubular cells against oxidant stress. Kidney Int 56:973-984, 1999
27. CHATTERJEE PK, ZACHAROWSKI K, CUZZOCREA S, et al: Inhibitors of poly (ADP-ribose) synthetase reduce renal ischemia-reperfusion injury in the anesthetized rat in vivo. FASEB J 14:641-651, 2000
28. BANASIK M, KOMURA H, SHIMOYAMA M, UEDA K: Specific inhibitors of poly (ADP-ribose)synthetase and mono (ADP-ribose) transferase. J Biol Chem 267:1569-1575, 1992
29. ASHWOOD-SMITH MJ: Radioprotective and cryoprotective properties of dimethyl sulphoxide in cellular systems. Ann NY Acad Sci 141:45-62, 1967
30. BANASIK M, UEDA K: Dual effects of dimethyl sulphoxide on poly (ADP-ribose) synthetase. J Enz Inhib 14:239-250, 1999
31. WRAY GM, HINDS C, THIEMERMANN C: Effects of inhibitors of poly (ADP-ribose) synthase activity on the hypotension and multiple organ dysfunction caused by endotoxin. Shock 10:13-19, 1998
32. MCDONALD MC, MOTA-FILIPE H, THIEMERMANN C: Effects of inhibitors of the activity of poly (ADP-ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 128:1339-1345, 1999
33. COSI C: New inhibitors of poly (ADP-ribose) polymerase and their potential therapeutic targets. Expert Opin Ther Patents 12:1047-1071, 2002
34. SUTO MJ, TURNER WR, ARUNDEL-SUTO CM, et al: Dihydroisoquinolinones: The design and synthesis of a new series of potent inhibitors of poly (ADP-ribose) polymerase. Antican Drug Des 6:107-117, 1991
35. WENKERT E, JOHNSTON DBR, DAVE KG: Derivatives of hemimellitic acid. A synthesis of erythrocentaurin. J Org Chem 29:2534-2542, 1964
36. MCDONALD MC, MOTA-FILIPE H, WRIGHT JA, et al: Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase on the organ injury and dysfunction caused by haemorrhagic shock. Br J Pharmacol 130:843-850, 2000
37. WAYMAN NS, MCDONALD MC, THOMPSON AC, et al: 5-Aminoisoquinolinone, a potent inhibitor of poly (adenosine 5′diphosphate ribose) polymerase, reduces myocardial infarct size. Eur J Pharmacol 430:93-100, 2001
38. MOTA-FILIPE H, SEPODES B, MCDONALD MC, et al: The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat. Med Sci Monit 8:BR444-BR453, 2002
39. SZABÓ G, BÄHRLE S, STUMPF N, et al: Poly (ADP-ribose) polymerase inhibition reduces reperfusion injury after heart transplantation. Circ Res 90:100-106, 2002
40. CUZZOCREA S, MCDONALD MC, MAZZON E, et al: Effects of 5-aminoisoquinolinone, a water-soluble, potent inhibitor of the activity of poly (ADP-ribose) polymerase, in a rodent model of lung injury. Biochem Pharmacol 63:293-304, 2002
41. SCHRAUFSTATTER IU, HINSHAW DB, HYSLOP PA, et al: Oxidant injury of cells. DNA strand breaks activate poly adenosine diphosphateribose polymerase and lead to depletion of nicotinamide adenine dinucleotide. J Clin Invest 77:1312-1320, 1986
42. CHATTERJEE PK, THIEMERMANN C: An in vivo model of ischemia/reperfusion and inflammation of the kidneys of the rat, in Methods in Molecular Biology, vol 225, edited by Winyard PG, Willoughby DA, Totowa, NJ, Humana Press, Inc., 2003, pp 223-237
43. WATSON CY, WHISH WJD, THREADGILL MD: Synthesis of 3-substituted benzamides and 5-substituted isoquinolin-1(2H)-ones and preliminary evaluation as inhibitors of poly (ADP-ribose) polymerase (PARP). Bioorg Med Chem 6:721-734, 1998
44. BOWES J, PIPER J, THIEMERMANN C: Inhibitors of the activity of poly (ADP-ribose) synthetase reduce the cell death caused by hydrogen peroxide in human cardiac myoblasts. Br J Pharmacol 124:1760-1766, 1998
45. BOWES J, MCDONALD MC, PIPER J, THIEMERMANN C: Inhibitors of poly (ADP-ribose) synthetase protect rat cardiomyocytes against oxidant stress. Cardiovasc Res 41:126-134, 1999
46. WILSON GL, PATTON NJ, MCCORD JM, et al: Mechanism of streptozotocin- and allotoxin-induced damage in rat B cells. Diabetologia 27:587-591, 1984
47. ALTHAUS FR, RICHTER C: ADP-ribosylation of proteins. Enzymology and biological significance. Mol Biol Biochem Biophys 37:1-237, 1987
48. REDEGELD FA, CHATTERJEE S, BERGER NA, SITKOVSKY MV: Poly (ADP-ribose) polymerase partially contributes to target cell death triggered by cytolytic T lymphocytes. J Immunol 149:3509-3516, 1992
49. THIEMERMANN C: Development of novel, water-soluble inhibitors of poly (adenosine 5′-diphosphate ribose) synthetase activity for use in shock and ischemia-reperfusion injury. Crit Care Med 30:1163-1165, 2002
50. VIRÁG L, SZABÓ C: The therapeutic potential of poly (ADP-ribose) polymerase inhibitors. Pharmacol Rev 54:375-429, 2002